Application of DERL1 gene promoter region methylation site in esophageal cancer diagnosis
The invention belongs to the technical field of biological medicines, and particularly relates to application of DERL1 gene promoter region methylation sites in esophageal cancer diagnosis. By detecting the expression level of DERL1 gene promoter region methylation sites in esophageal cancer tissues...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG WENJIE ZHANG LOUQIAN CHEN YUNZHAO WANG TAO LI FENG SUN MENGFEI REN WEI CUI XIAOBIN MENG FANQING SUN SHUYAN YANG JU ZHOU ZIRU NIE LING YU JIE |
| description | The invention belongs to the technical field of biological medicines, and particularly relates to application of DERL1 gene promoter region methylation sites in esophageal cancer diagnosis. By detecting the expression level of DERL1 gene promoter region methylation sites in esophageal cancer tissues and paracancerous normal tissues or the expression level of DERL1 genes, it is indicated that the average methylation level in esophageal squamous cell carcinoma tissues is lower than that in the paracancerous normal tissues, and the difference has statistical significance; meanwhile, the expression of the DERL1 protein in the esophageal squamous carcinoma is obviously higher than that of para-carcinoma normal tissues, and the difference has statistical significance. Therefore, the DERL1 gene or the DERL1 gene promoter region methylation site in the esophageal cancer can be used for diagnosis, adjuvant therapy and prognosis evaluation of the esophageal cancer as a detection marker.
本发明属于生物医药技术领域，具体涉及DERL1基因启动子区甲基化 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116837100A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116837100A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116837100A3</originalsourceid><addsrcrecordid>eNrjZIh0LCjIyUxOLMnMz1PIT1NwcQ3yMVRIT81LVSgoys_NL0ktUihKTQfJ5qaWZFTmQFQWZ5akKmTmKaQW5xdkJKanJuYoJCfmJQMVp2QmpuflF2cW8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxGSgJSXxzn6GhmYWxuaGBgaOxsSoAQChQDpS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of DERL1 gene promoter region methylation site in esophageal cancer diagnosis</title><source>esp@cenet</source><creator>WANG WENJIE ; ZHANG LOUQIAN ; CHEN YUNZHAO ; WANG TAO ; LI FENG ; SUN MENGFEI ; REN WEI ; CUI XIAOBIN ; MENG FANQING ; SUN SHUYAN ; YANG JU ; ZHOU ZIRU ; NIE LING ; YU JIE</creator><creatorcontrib>WANG WENJIE ; ZHANG LOUQIAN ; CHEN YUNZHAO ; WANG TAO ; LI FENG ; SUN MENGFEI ; REN WEI ; CUI XIAOBIN ; MENG FANQING ; SUN SHUYAN ; YANG JU ; ZHOU ZIRU ; NIE LING ; YU JIE</creatorcontrib><description>The invention belongs to the technical field of biological medicines, and particularly relates to application of DERL1 gene promoter region methylation sites in esophageal cancer diagnosis. By detecting the expression level of DERL1 gene promoter region methylation sites in esophageal cancer tissues and paracancerous normal tissues or the expression level of DERL1 genes, it is indicated that the average methylation level in esophageal squamous cell carcinoma tissues is lower than that in the paracancerous normal tissues, and the difference has statistical significance; meanwhile, the expression of the DERL1 protein in the esophageal squamous carcinoma is obviously higher than that of para-carcinoma normal tissues, and the difference has statistical significance. Therefore, the DERL1 gene or the DERL1 gene promoter region methylation site in the esophageal cancer can be used for diagnosis, adjuvant therapy and prognosis evaluation of the esophageal cancer as a detection marker.
本发明属于生物医药技术领域，具体涉及DERL1基因启动子区甲基化</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CN&NR=116837100A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231003&DB=EPODOC&CC=CN&NR=116837100A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG WENJIE</creatorcontrib><creatorcontrib>ZHANG LOUQIAN</creatorcontrib><creatorcontrib>CHEN YUNZHAO</creatorcontrib><creatorcontrib>WANG TAO</creatorcontrib><creatorcontrib>LI FENG</creatorcontrib><creatorcontrib>SUN MENGFEI</creatorcontrib><creatorcontrib>REN WEI</creatorcontrib><creatorcontrib>CUI XIAOBIN</creatorcontrib><creatorcontrib>MENG FANQING</creatorcontrib><creatorcontrib>SUN SHUYAN</creatorcontrib><creatorcontrib>YANG JU</creatorcontrib><creatorcontrib>ZHOU ZIRU</creatorcontrib><creatorcontrib>NIE LING</creatorcontrib><creatorcontrib>YU JIE</creatorcontrib><title>Application of DERL1 gene promoter region methylation site in esophageal cancer diagnosis</title><description>The invention belongs to the technical field of biological medicines, and particularly relates to application of DERL1 gene promoter region methylation sites in esophageal cancer diagnosis. By detecting the expression level of DERL1 gene promoter region methylation sites in esophageal cancer tissues and paracancerous normal tissues or the expression level of DERL1 genes, it is indicated that the average methylation level in esophageal squamous cell carcinoma tissues is lower than that in the paracancerous normal tissues, and the difference has statistical significance; meanwhile, the expression of the DERL1 protein in the esophageal squamous carcinoma is obviously higher than that of para-carcinoma normal tissues, and the difference has statistical significance. Therefore, the DERL1 gene or the DERL1 gene promoter region methylation site in the esophageal cancer can be used for diagnosis, adjuvant therapy and prognosis evaluation of the esophageal cancer as a detection marker.
本发明属于生物医药技术领域，具体涉及DERL1基因启动子区甲基化</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIh0LCjIyUxOLMnMz1PIT1NwcQ3yMVRIT81LVSgoys_NL0ktUihKTQfJ5qaWZFTmQFQWZ5akKmTmKaQW5xdkJKanJuYoJCfmJQMVp2QmpuflF2cW8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxGSgJSXxzn6GhmYWxuaGBgaOxsSoAQChQDpS</recordid><startdate>20231003</startdate><enddate>20231003</enddate><creator>WANG WENJIE</creator><creator>ZHANG LOUQIAN</creator><creator>CHEN YUNZHAO</creator><creator>WANG TAO</creator><creator>LI FENG</creator><creator>SUN MENGFEI</creator><creator>REN WEI</creator><creator>CUI XIAOBIN</creator><creator>MENG FANQING</creator><creator>SUN SHUYAN</creator><creator>YANG JU</creator><creator>ZHOU ZIRU</creator><creator>NIE LING</creator><creator>YU JIE</creator><scope>EVB</scope></search><sort><creationdate>20231003</creationdate><title>Application of DERL1 gene promoter region methylation site in esophageal cancer diagnosis</title><author>WANG WENJIE ; ZHANG LOUQIAN ; CHEN YUNZHAO ; WANG TAO ; LI FENG ; SUN MENGFEI ; REN WEI ; CUI XIAOBIN ; MENG FANQING ; SUN SHUYAN ; YANG JU ; ZHOU ZIRU ; NIE LING ; YU JIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116837100A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG WENJIE</creatorcontrib><creatorcontrib>ZHANG LOUQIAN</creatorcontrib><creatorcontrib>CHEN YUNZHAO</creatorcontrib><creatorcontrib>WANG TAO</creatorcontrib><creatorcontrib>LI FENG</creatorcontrib><creatorcontrib>SUN MENGFEI</creatorcontrib><creatorcontrib>REN WEI</creatorcontrib><creatorcontrib>CUI XIAOBIN</creatorcontrib><creatorcontrib>MENG FANQING</creatorcontrib><creatorcontrib>SUN SHUYAN</creatorcontrib><creatorcontrib>YANG JU</creatorcontrib><creatorcontrib>ZHOU ZIRU</creatorcontrib><creatorcontrib>NIE LING</creatorcontrib><creatorcontrib>YU JIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG WENJIE</au><au>ZHANG LOUQIAN</au><au>CHEN YUNZHAO</au><au>WANG TAO</au><au>LI FENG</au><au>SUN MENGFEI</au><au>REN WEI</au><au>CUI XIAOBIN</au><au>MENG FANQING</au><au>SUN SHUYAN</au><au>YANG JU</au><au>ZHOU ZIRU</au><au>NIE LING</au><au>YU JIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of DERL1 gene promoter region methylation site in esophageal cancer diagnosis</title><date>2023-10-03</date><risdate>2023</risdate><abstract>The invention belongs to the technical field of biological medicines, and particularly relates to application of DERL1 gene promoter region methylation sites in esophageal cancer diagnosis. By detecting the expression level of DERL1 gene promoter region methylation sites in esophageal cancer tissues and paracancerous normal tissues or the expression level of DERL1 genes, it is indicated that the average methylation level in esophageal squamous cell carcinoma tissues is lower than that in the paracancerous normal tissues, and the difference has statistical significance; meanwhile, the expression of the DERL1 protein in the esophageal squamous carcinoma is obviously higher than that of para-carcinoma normal tissues, and the difference has statistical significance. Therefore, the DERL1 gene or the DERL1 gene promoter region methylation site in the esophageal cancer can be used for diagnosis, adjuvant therapy and prognosis evaluation of the esophageal cancer as a detection marker.
本发明属于生物医药技术领域，具体涉及DERL1基因启动子区甲基化</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116837100A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
| title | Application of DERL1 gene promoter region methylation site in esophageal cancer diagnosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A06%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20WENJIE&rft.date=2023-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116837100A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |